Dermisonics Financial Statements From 2010 to 2024

Dermisonics financial statements provide useful quarterly and yearly information to potential Dermisonics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Dermisonics financial statements helps investors assess Dermisonics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Dermisonics' valuation are summarized below:
Dermisonics does not presently have any fundamental signals for analysis.
Check Dermisonics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dermisonics main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Dermisonics financial statements analysis is a perfect complement when working with Dermisonics Valuation or Volatility modules.
  
This module can also supplement various Dermisonics Technical models . Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

Dermisonics Company Shares Outstanding Analysis

Dermisonics' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Dermisonics Shares Outstanding

    
  63.91 M  
Most of Dermisonics' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dermisonics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition
Based on the latest financial disclosure, Dermisonics has 63.91 M of shares currently outstending. This is much higher than that of the sector and significantly higher than that of the Shares Outstanding industry. The shares outstanding for all United States stocks is notably lower than that of the firm.

Dermisonics Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Dermisonics's current stock value. Our valuation model uses many indicators to compare Dermisonics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Dermisonics competition to find correlations between indicators driving Dermisonics's intrinsic value. More Info.
Dermisonics is rated # 5 in return on equity category among related companies. It is rated below average in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Dermisonics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Dermisonics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Dermisonics' earnings, one of the primary drivers of an investment's value.

About Dermisonics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Dermisonics income statement, its balance sheet, and the statement of cash flows. Dermisonics investors use historical funamental indicators, such as Dermisonics's revenue or net income, to determine how well the company is positioned to perform in the future. Although Dermisonics investors may use each financial statement separately, they are all related. The changes in Dermisonics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Dermisonics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Dermisonics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Dermisonics. Please read more on our technical analysis and fundamental analysis pages.
Dermisonics, Inc. manufactures ultrasonic transdermal drug-delivery technologies and equipment. Dermisonics, Inc. was founded in 2000 and is based in Irvine, California. Dermisonics is traded on OTC Exchange in the United States.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Dermisonics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Dermisonics' short interest history, or implied volatility extrapolated from Dermisonics options trading.

Pair Trading with Dermisonics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dermisonics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermisonics will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Dermisonics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dermisonics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dermisonics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dermisonics to buy it.
The correlation of Dermisonics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dermisonics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dermisonics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dermisonics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Consideration for investing in Dermisonics Stock

If you are still planning to invest in Dermisonics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Dermisonics' history and understand the potential risks before investing.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm